{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:06:02Z","timestamp":1748664362808,"version":"3.41.0"},"reference-count":0,"publisher":"Kare Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pract Res"],"DOI":"10.14744\/cpr.2025.94220","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T07:05:02Z","timestamp":1748588702000},"page":"148-155","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Retinoic Acid and Bevacizumab on Ovarian Hyperstimulation Syndrome"],"prefix":"10.14744","volume":"47","author":[{"given":"Fatma","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5966","published-online":{"date-parts":[[2025]]},"container-title":["Journal of Clinical Practice and Research"],"original-title":[],"link":[{"URL":"https:\/\/jcpres.com\/storage\/upload\/pdfs\/1742817815-en.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T07:05:04Z","timestamp":1748588704000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcpres.com\/article\/2726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.14744\/cpr.2025.94220","relation":{},"ISSN":["2980-2156"],"issn-type":[{"value":"2980-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}